2020
DOI: 10.4269/ajtmh.20-0281
|View full text |Cite
|
Sign up to set email alerts
|

All together to Fight COVID-19

Abstract: Novel coronavirus disease , named a pandemic by the WHO, is the current global health crisis. National and international collaboration are indispensable for combating COVID-19 and other similar potential outbreaks. International efforts to tackle this complex problem have led to remarkable scientific advances. Yet, as a global society, we can and must take additional measures to fight this pandemic. Undoubtedly, our approach toward COVID-19 was not perfect, and testing has not been deployed fast enough to arre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
61
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
9
1

Relationship

6
4

Authors

Journals

citations
Cited by 92 publications
(61 citation statements)
references
References 7 publications
(5 reference statements)
0
61
0
Order By: Relevance
“…COVID-19 has continued human-to-human transmission regardless of the triad of knowledge (both professional and nonprofessional) (Moazzami et al 2020), biological factors (both men and women), and the physiological condition (Mirbeyk and Rezaei 2020;Saghazadeh and Rezaei 2020a). In such critical time, it is not difficult to remember the previous pandemics (Jabbari et al 2020), though none of the lessons learned could be satisfactory, revealing with the COVID-19 pandemic the limitation of national strategies and the need for reliable research and international collaboration (Kafieh et al 2020;Mohamed et al 2020a;Momtazmanesh et al 2020;Moradian et al 2020;Rzymski et al 2020). After the six-month effort, there is a lack of specific treatment and vaccine, though numerous efforts have taken place to find potential therapeutic and preventive options (Moazzami et al 2020;Rabiee et al 2020;Yazdanpanah et al 2020) from repurposing drugs (Mohamed et al 2020b) and the design and manufacturing of antibodies (Jahanshahlu and Rezaei 2020b) to the development of cell-based therapies (Basiri et al 2020).…”
Section: Resultsmentioning
confidence: 99%
“…COVID-19 has continued human-to-human transmission regardless of the triad of knowledge (both professional and nonprofessional) (Moazzami et al 2020), biological factors (both men and women), and the physiological condition (Mirbeyk and Rezaei 2020;Saghazadeh and Rezaei 2020a). In such critical time, it is not difficult to remember the previous pandemics (Jabbari et al 2020), though none of the lessons learned could be satisfactory, revealing with the COVID-19 pandemic the limitation of national strategies and the need for reliable research and international collaboration (Kafieh et al 2020;Mohamed et al 2020a;Momtazmanesh et al 2020;Moradian et al 2020;Rzymski et al 2020). After the six-month effort, there is a lack of specific treatment and vaccine, though numerous efforts have taken place to find potential therapeutic and preventive options (Moazzami et al 2020;Rabiee et al 2020;Yazdanpanah et al 2020) from repurposing drugs (Mohamed et al 2020b) and the design and manufacturing of antibodies (Jahanshahlu and Rezaei 2020b) to the development of cell-based therapies (Basiri et al 2020).…”
Section: Resultsmentioning
confidence: 99%
“…To prevent disease spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), human gatherings of any kind have been limited and replaced with alternative options such as remote working, virtual or hybrid education and conferences, and cancellation of many in-person social or religious events as well as overseas travel (5). Governments decided to set more limits and borders for people, while the virus does not know any border (6,7). Although such restrictive policies might be the only viable option in the short-run, they are not cost-effective, efficient, and even feasible in the mid-and long-term scenarios for many businesses and countries in cases of prolonged global disasters such as the COVID-19 pandemic, especially in low-and middle-income countries.…”
Section: Limitations Due To Covid-19mentioning
confidence: 99%
“…Since the outbreak of the COVID-19 pandemic, various studies were conducted to investigate its effect on the economy, including its impact on the correlations between crude oil and agricultural futures [ 1 ], co-movement between COVID-19 and Bitcoin [ 2 ], the tourism industry [ 3 ], the covariance between temperature, COVID-19 and exchange rate in Wuhan [ 4 ], Italian manufacturing firms [ 5 ], B2B sales forces [ 6 ], efficiency of equity and cryptocurrency markets [ 7 ], airline employment [ 8 ], entrepreneurial uncertainty [ 9 ], consumer behavior [ 10 ], marketing innovations [ 11 ], corporate social responsibility and marketing [ 12 ], and randomness and mutual information between markets [ 13 ], to name few. In addition, other interesting studies focused on the forecasting of new cases [ 14 ] and knowledge sharing and collaboration for preparedness to fight the pandemics [ 15 ].…”
Section: Introductionmentioning
confidence: 99%